TCL Archive Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds January 29, 2010
TCL Archive Senate Committee Ok’s $1.9 Billion Budget For NCI, Same As House Appropriation July 29, 1994
TCL Archive Cooperative Groups Advised to Prepare for 10 Percent Budget Cut, Begin Slowing Patient Accrual. Groups Say Cuts Would Jeopardize Clinical Trials Program. October 27, 2006
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: Reauthorization Bill Could Go To House Floor Next Week; Packwood Blocks Action In Senate July 8, 1983
